PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models

Journal:

Brain

Published:

2025-10-16

DOI:

10.1093/brain/awaf372

Affiliations:

9

Authors:

18

Go to article

Institutions	Authors	Share
The University of Queensland (UQ), Australia	13.000000 13.000000	0.72
Inflazome, United Kingdom (UK)	2.500000	0.14
Sitala Bio, United Kingdom (UK)	1.500000	0.08
Translational Research Institute (TRI), Australia	0.500000	0.03
Queen's University Belfast (QUB), United Kingdom (UK)	0.500000	0.03

Interested in Neurosciences?